Pleuramesotheliom

  • N. Konietzko
  • H. Teschler

Zusammenfassung

Das diffuse, maligne Pleuramesotheliom ist definiert als ein autochthoner, bösartiger Tumor der Pleura, der von der Mesothelzelle ausgeht. Synonym gebraucht werden „diffuses Pleuramesotheliom“, „diffuses malignes Mesotheliom (DMM)“ und „malignes Mesotheliom“. Die Herkunft des malignen Pleuramesothelioms aus der Mesothelzelle ist in Gewebekulturen nachgewiesen. Die gleiche prospektive Potenz zur malignen Entartung scheint auch der Mesothelzelle des Perikards und des Peritoneums zu eigen zu sein (7,132).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Acheson ED, Gardner J J (1979) Mesothelioma and exposure to mixture of chrysotile and amphibole asbestos. Arch Environ Health 34: 240–242PubMedGoogle Scholar
  2. 2.
    Aisner J, Sigman LM (1987) The role of chemotherapy in the treatment of malignant mesothelioma. Grune & Stratton Inc., London, p 385Google Scholar
  3. 3.
    Alexander E, Clark RA, Colley DP, Mitchell SE (1981) CT of malignant pleural mesothelioma. Am J Roentgenol 137: 287–291Google Scholar
  4. 4.
    Anderson HA, Lilis R, Daum SM et al (1976) Household-contact asbestos neoplastic risk. Ann NY Acad Sci 271: 311–323PubMedGoogle Scholar
  5. 5.
    Anspach M, Roitzsch E, Clausnitzer W (1965) Ein Beitrag zur Ätiologie des diffusen malignen Pleuramesothelioms. Int Arch Gewerbepath 21: 392Google Scholar
  6. 6.
    Antman KH (1980) Malignant mesothelioma. N Engl J Med 303: 200–202PubMedGoogle Scholar
  7. 7.
    Antman K, Aisner J (1987) Asbestos-related malignancy. Grüne & Stratton, LondonGoogle Scholar
  8. 8.
    Artvinli M, Baris YI (1979) Malignant mesotheliomas in a small village in an Anatolian region of Turkey: an epidemiologic study. J Natl Cancer Ind 63: 17–22Google Scholar
  9. 9.
    Artvinli M, Sahin AA, Altinors M, Baris YI (1981) Thoracoscopy in the diagnosis of environmental natural mineral fiber-induced diseases. Poumon Coeur 37: 245–247PubMedGoogle Scholar
  10. 10.
    Ashbaugh DG (1980) Discussion to: Baumgartner WA, Mark JBD: The use of thoracoscopy in the diagnosis of pleural disease. Arch Surg 115: 420–421Google Scholar
  11. 11.
    Aurand K, Kierski WS (eds) (1981) Gesundheitliche Risiken von Asbest. Eine Stellungnahme des Bundesgesundheitsamtes. BGA Berichte 4, Reimer, BerlinGoogle Scholar
  12. 12.
    Baris YI, Savachi R, Simonato L et al (1978) An outbreak of pleural mesothelioma and chronic fibrosis pleurity in the village of Karain/Urgüp in Anatolia. Thorax 33: 181–192PubMedGoogle Scholar
  13. 13.
    Baris YI, Saracci R, Simonato L, Skidmore JW, Artvinli M (1981) Malignant mesothelioma and radiological chest abnormalities in two villages in Central Turkey - an epidemiological and environmental investigation. Lancet 2: 894–987Google Scholar
  14. 14.
    Battifora H, Kopinski MI (1985) Distinction of mesothelioma from adenocarcinoma. An immunhistochemical approach. Cancer 55: 1679–1685Google Scholar
  15. 15.
    Bayly TC (1978) Tetracycline and quinacrine in the control of malignant pleural effusions. A randomized trial. Cancer 41: 1188–1192PubMedGoogle Scholar
  16. 16.
    Beck P, Irmscher G (1979) Extrathorakale Mesotheliome durch Inhalation von Asbeststaub. Z Erkrank Atm org 159: 282–290Google Scholar
  17. 17.
    Beck EG, Bödeker RH, Schmidt P (1988) Retrospektive epidemiologische Untersuchungen in der deutschen Faserzement-Industrie (1981–1986). Arbeitsmedizin-Sozialmedizin-Präventivmedizin 10: 241Google Scholar
  18. 18.
    Becklake MR (1976) Asbestos-related diseases of the lung and other organs: Their epidemiology and implications for clinical practice. Am Rev Respir Dis 144: 187–227Google Scholar
  19. 19.
    Bignon J, Sébastien P, Di Menza L et al (1979) Registre français des mesothelioms 1965–1978. Rev Fr Mal Respir 7: 223–242PubMedGoogle Scholar
  20. 20.
    Bittersohl G, Ose H (1971) Zur Epidemiologie des Pleuramesothelioms. Z ges Hyg 17: 861–869Google Scholar
  21. 21.
    Blount HC jr (1956) Localized mesothelioma of the pleura. A review with six new cases. Radiology 67: 822–834PubMedGoogle Scholar
  22. 22.
    Boersma A, Degand P, Havez R (1973) Diffuse mesothelioma: Biochemical stages in the diagnosis, detection and measurement of hyaluronic acid in pleural fluis. In: Bogovski P, Gilson JD, Timbrell V et al (eds) Biological Effects of Asbestos. IARC, Scientific Publications (Lyon), p 65–67Google Scholar
  23. 23.
    Bohlig H, Otto H (1975) Asbest und Mesotheliom. Fakten, Fragen, Umweltprobleme. Thieme, StuttgartGoogle Scholar
  24. 24.
    Bohlig H (1976) Pneumokoniosen nach Inhalation vorwiegend silikathaltiger Stäube. In: Ulmer WT, Reichel G (Hrsg) Handbuch der inneren Medizin, Bd. IV/1: Pneumokoniosen. Springer, Berlin Heidelberg, p 389–466Google Scholar
  25. 25.
    Borow M, Couston A, Livornese L et al (1973) Mesotheliom following exposure to asbestos. A review of 72 cases. Chest 64: 641PubMedGoogle Scholar
  26. 26.
    Bouchee W (1974) Zur Wohntopographie der Mesotheliome in Hamburg (außerhalb beruflicher und intradomizilärer Asbestexposition). Dissertation, HamburgGoogle Scholar
  27. 27.
    Boutin C, Viallet JR, Cargmimo P, Farisse P (1981) Thoracoscopy in malignant pleural effusion. Am Rev Respir Dis 123: 588–592Google Scholar
  28. 29.
    Boutin C, Viallat JR, Rey F (1987) Thoracoscopy in the diagnosis, prognosis and treatment of mesothelioma. Grune & Stratton Inc, London, p 301Google Scholar
  29. 28.
    Boutin C, Viallat JR, Cargmimo P, Faresse P (1984) Thoracoscopic assessment of lung asbestos contens. In: Gee JBL, Keith W, Morgan C, Brooks MS (eds) Occupational lung diseases. Raven, New York, p 229–230Google Scholar
  30. 30.
    Brandt HJ, Loddenkemper R, Mai J (1983) Atlas der diagnostischen Thorakoskopie. Thieme, StuttgartGoogle Scholar
  31. 31.
    Brenner M, Loddenkemper R, Brandt HJ (1981) Saugdrainage und Verödungstherapie bei thorakoskopisch gesicherten malignen Pleuraergüssen - Vergleich zwischen Thiotepa und Tetracyclin. Kongr Ber Wiss Tag Norddtsch Ges Lungen- u Bronchialheilk 17: 169–172Google Scholar
  32. 32.
    Brenner J, Sordillo PP, Magill GB, Golbey RB (1982) Malignant mesothelioma of the pleura. Review of 123 patients. Cancer 49: 2431–2435PubMedGoogle Scholar
  33. 33.
    Briselli MF, Mark E J (1987) Solitary fibrous tumors of the pleura and benign extrapleural tumors of mesothelial origin. Grune & Stratton Inc., London, p 165Google Scholar
  34. 34.
    Butchart EG, Ashcroft T, Barnsley WE et al (1976) Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 31: 15–24PubMedGoogle Scholar
  35. 35.
    Butler EB, Berry AV (1973) Diffuse mesotheliomas: Diagnostic criteria using exfoliative cytology. In: Bogovski P, Gilson JD, Timbrell V et al (eds) Biological Effects of Asbestos. LARC, Scientific Publications (Lyon), p 68–73Google Scholar
  36. 36.
    Calavrezos A, Hain E (1982) Malignes diffuses Pleuramesotheliom: Sicherung der Diagnose. Dtsch med Wsehr 107: 903–906Google Scholar
  37. 37.
    Campbell GD, Greenberg SD (1981) Pleural mesothelioma with calcified liver metastases. Chest 79: 229–230PubMedGoogle Scholar
  38. 38.
    Canto A, Blasco E, Casillas M et al (1977) Thoracoscopy in the diagnosis of pleura effusion. Thorax 32: 550–554PubMedGoogle Scholar
  39. 39.
    Chahinian AP (1983) Therapeutic modalities in malignant pleural mesothelioma. In: Chretien J, Hirsch A (eds) Diseases of the pleura. Masson, New YorkGoogle Scholar
  40. 40.
    Chahinian AP (1985) Management of pleural tumors and malignant pleural effusions. In: Chretien J, Bignon J, Hirsch A (eds) The pleura in health and disease. Dekker, New York, p 571–584Google Scholar
  41. 41.
    Chiu B, Churg A, Tengblad A, Pearce R, McCaughey WT (1984) Analysis of hyaluronic acid in the diagnosis of malignant mesothelioma. Cancer 54: 2195–2199PubMedGoogle Scholar
  42. 42.
    Chretien J, Hirsch A (1983) Diseases of the pleura. Masson, New YorkGoogle Scholar
  43. 43.
    Chretien J, Bignon J, Hirsch A (1985) The pleura in health and diseae. Dekker, New YorkGoogle Scholar
  44. 44.
    Churg J, Rosen SH, Moolten S (1965) Histological characteristics of mesothelioma associated with asbestos. Ann N Y Acad Sci 132: 614–622PubMedGoogle Scholar
  45. 45.
    Clagett OT, McDonald JR, Schmidt HW (1952) Localized fibrous mesothelioma of the pleura. J Thorac Surg 24: 213–220PubMedGoogle Scholar
  46. 46.
    Corson JM (1987) Pathology of malignant mesothelioma. Grune & Stratton Inc., London, p 179Google Scholar
  47. 47.
    Couch WD (1981) Combined effusion fluid tumor marker assay, carcinoembryonic antigen (CEA) and human chorionic gonadotropin (hCG), in the detection of malignant tumors. Cancer 48: 2475–2479PubMedGoogle Scholar
  48. 48.
    Craighead JE, Mossman BT (1982) The pathogenesis of asbestos-associated disease. New Engl J Med 306 (24): 1446–1455PubMedGoogle Scholar
  49. 49.
    Dach J, Campbell WT (1980) Peritoneal mesothelioma: CT, sonography, and Gallium–67 scan. AJR 135: 614–615PubMedGoogle Scholar
  50. 50.
    Dalquen P, Dabbert AF, Hinz I (1969) Zur Epidemiologie der Pleuramesotheliome. Prax Pneumol 23: 547PubMedGoogle Scholar
  51. 51.
    Dalton WT, Zolliken AS, MacCaughey W et al (1979) Localized primary tumors of the pleura. An analysis of 40 cases. Cancer 44: 1465–1475PubMedGoogle Scholar
  52. 52.
    Davis D (1984) Are all mesotheliomas due to asbestos? Brit Med J 289: 1164–1165Google Scholar
  53. 53.
    Delaria GA, Jensik R, Faber P et al (1978) Surgical management of malignant mesothelioma. Ann Thorax Durg 26: 375–382Google Scholar
  54. 54.
    Dewald G, Dines D, Weiland L et al (1976) Usefulness of chromosome examination in the diagnosis of malignant pleura effusion. N Eng J Med 295: 1494–1500Google Scholar
  55. 55.
    Dimitrov NV, McMahon S (1987) Presentation, diagnostic methods, staging, and natural history of malignant mesothelioma. Grune & Stratton Inc, London, p 225Google Scholar
  56. 56.
    Eimes PC (1973) The natural history of diffuse mesothelioma. In: Bogovski P, Gilson JD, Timbrell V et al (eds) Biological effects of asbestos. IARC, Scientific Publications (Lyon), p 267–272Google Scholar
  57. 57.
    Eimes PC, Simpson MJC (1976) The clinicals aspects of mesothelioma. Q J Med 179 (45): 427–449Google Scholar
  58. 58.
    Eimes PC (1980) Mesotheliomas, minerals and man-made mineral fibres. Thorax 25: 561–563Google Scholar
  59. 59.
    Engel J (1981) Tetracyclin- und Na-OH-Pleurodese in der Palliativbehandlung maligner Pleuraergüsse. Prax Pneumol 36: 1124–1128Google Scholar
  60. 60.
    Engelmann C, Thamm W (1975) Klinischer Beitrag zum diffusen Pleuramesotheliom. Zentralbl Chir 100: 266–276PubMedGoogle Scholar
  61. 61.
    Enterline PE, Henderson V (1973) Type of asbestos and respiratory cancer in the asbestos industry. Arch Environ Health 27: 312–317PubMedGoogle Scholar
  62. 62.
    Epler GR, Fitzgerald MX, Gaensler EA et al (1980) Asbestos-related disease from household exposure. Respiration 39: 229–240PubMedGoogle Scholar
  63. 63.
    Falor WH, Ward RM, Brezler MR (1982) Diagnosis of pleura effusions by chromosome analysis. Chest 81: 193–197PubMedGoogle Scholar
  64. 64.
    Förster H (1982) Eine mineralogisch-petrographische Untersuchung über mögliche Ursachen von Mesotheliomen in Kappadozien/Türkei. Zbl Arbeitsmed 32: 18–27Google Scholar
  65. 65.
    Förster H, Grimm H, Mayer PL et al (1984) Künstliche Mineralfasern am Arbeitsplatz. Zbl Arbeitsmed 34: 362–371Google Scholar
  66. 66.
    Gibbs AR (1990) Role of asbestos and other fibres in the development of diffuse malignant mesothelioma. Thorax 45: 649–654PubMedGoogle Scholar
  67. 67.
    Gilson JC (1973) Asbestos cancer. Past and future hazards. Proc R Soc Med 66: 395–403PubMedGoogle Scholar
  68. 68.
    Godwin MC, Jagatic J (1972) Asbestos and mesotheliomas. Environ Res 3: 391–416Google Scholar
  69. 69.
    Grant DC, Seltzer SE, Amtman KH, Finberg HJ, Koster K (1983) Computed tomography of malignant pleural mesothelioma. J Comput Assist Tomogr 7: 626–632PubMedGoogle Scholar
  70. 70.
    Greb KH, Ludes H, Teutler HJ (1982) Zur Ergänzung der Diagnostik von Pleuraerkrankungen durch die Computertomographie. Prax Pneumol 36: 84–88Google Scholar
  71. 71.
    Greenberg M, Davis Lloyd TA (1974) Mesothelioma register 1967–1968. Br J Ind Med 31: 91–104PubMedGoogle Scholar
  72. 72.
    Griffiths MH, Riddell RX, Xippell JM (1980) Malignant mesothelioma. A review of 35 cases with diagnosis and prognosis. Pathology 12: 591–603PubMedGoogle Scholar
  73. 73.
    Guzmann J, Bross KJ, Würtemberger G, Costabel U (1989) Immunocytology in malignant pleural mesothelioma. Chest 95: 590–595Google Scholar
  74. 74.
    Hain E (1974)Katamnestisehe Untersuchungen zur Genese des Mesothelioms. Bericht über 150 Fälle aus dem Hamburger Raum. Int Arch Arbeitsmed 33: 15–37Google Scholar
  75. 75.
    Hartman CA (1985) Das Pleuramesotheliom im Sektionsgut des Instituts für Pathologie am Krankenhaus Spandau. Prax Klin Pneumol 39: 59–64Google Scholar
  76. 76.
    Harwood TR, Gracey DR, Yokoo H (1976) Pseudomesotheliomatous carcinoma of the lung. A variant of peripheral lung cancer. Am J Clin Pathol 65: 159–167Google Scholar
  77. 77.
    Hasan FM, Nash G, Kazemi H (1977) The significance of asbestos exposure in the diagnosis of mesothelioma: A 28-year experience from a Major Urban Hospital. Am Rev Respir Dis 115: 761–768PubMedGoogle Scholar
  78. 78.
    Haslam PL, Hirton CWG, Lukosek A et al (1980) Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax 35: 328–339PubMedGoogle Scholar
  79. 79.
    Heller RM, Jnaower ME, Weber AL (1973) The radiological manifestations of malignant pleural mesothelioma. Radiology 108: 53–59Google Scholar
  80. 80.
    Herbert A (1984) Editorial - The diagnosis of malignant mesothelioma. J Pathol 143: 145–146PubMedGoogle Scholar
  81. 81.
    Herbert A, Gallagher PJ (1982) Pleural biopsy in the diagnosis of malignant mesothelioma. Thorax 37: 816–821PubMedGoogle Scholar
  82. 82.
    Hirsch A, Brochard P, DeCremoux H, Erkam L, Sebastien P, Di Menza L, Bignon J (1982) Features of asbestos-exposed and unexposed mesothelioma. Am J Ind Med 3: 413–422PubMedGoogle Scholar
  83. 83.
    Holden J, Churg JA (1984) Immunhistochemical staining for ceratin and carcinoembryocin antigen in the diagnosis of malignant mesothelioma. Am J Surg Pathol 8: 277–279PubMedGoogle Scholar
  84. 84.
    Järvi OH, Kumas R, Laitio R et al (1972) The accuracy and significance of cytologic cancer diagnosis of pleural effusions. Acta Cytol 18: 152–158Google Scholar
  85. 85.
    Jaurand MC, Kaplan H, Thiollet J et al (1979) Phagocytosis of chrysotile fibers by pleural mesothelial cells in culture. Am J Pathol 94: 529–538PubMedGoogle Scholar
  86. 86.
    Kannerstein M, Churg J, Magner D (1973) Histochemical studies of mesothelioma. In: Bogovski P, Gilson JD, Timbrell V et al (eds) Biological effects of asbestos, IARC, Scientific Publications (Lyon), p 62–64Google Scholar
  87. 87.
    Kannerstein M, Churg J, Magner D (1977) A critique of the criteria for the diagnosis of diffuse malignant mesothelioma. Mt Sinai J Med 44: 485–494PubMedGoogle Scholar
  88. 88.
    Kappes R, Schulte R, Greschuchen D, Maassen W (1981) Ergebnisse der kurativen und palliativen operativen Behandlung primärer und sekundärer maligner Pleuratumoren. Prax Pneumol 35: 935–937Google Scholar
  89. 89.
    Knappmann J (1972) Beobachtungen an 251 obduzierten Mesotheliom-Fällen in Hamburg (1958–1968). Pneumologie 148: 60–65Google Scholar
  90. 90.
    Koch B (1989) Pleura- und Peritoneal-Mesotheliome im Bereich der Berufsgenossenschaft der chemischen Industrie (1975–1987). Unfallversicherung 20: 202–212Google Scholar
  91. 91.
    Korsgaard D (1979) Chromosome analysis of malignant human effusions in vivo. Scand J Respir Dis 105: 1–100Google Scholar
  92. 92.
    Kuntz E (1968) Die Pleuraergüsse. Differentialdiagnose, Klinik und Therapie. Urban & Schwarzenberg, München Berl in WienGoogle Scholar
  93. 93.
    Law MR, Greogor A, Husband JE et al (1982) Computed tomography in the assessment of malignant mesothelioma of the pleura. Clin Radiol 33: 67–70PubMedGoogle Scholar
  94. 94.
    Law MR, Hodson ME, Heard BE (1982) Malignant mesothelioma of the pleura: Relation between histological type and clinical behaviour. Thorax 37: 810–815Google Scholar
  95. 95.
    Law MR, Hodson ME, Turner-Warwick M (1984) Malignant mesothelioma of the pleura. Clinical aspects and symptomatic treatment. Eur J Resp Dis 65: 162–168Google Scholar
  96. 96.
    Lederman G, Recht A (1987) Radiation therapy of peritoneal mesothelioma. Grune & Stratton Inc., London, p 367Google Scholar
  97. 97.
    Lee I, Radosevich JA, Chejfee G, Ma YX, Wannen WH, rosen ST, Gould VE (1986) Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinoma using monoclonal antibodies 44–3A6 and 624A12. Am J Pathol 123: 487–507Google Scholar
  98. 98.
    Legha SS, Muggia FM ( 1977 a) Pleural mesothelioma: Clinical feature and therapeutic implications. Ann Intern Med 87: 613–621Google Scholar
  99. 99.
    Legha SS, Muggia FM (1977 b) Therapeutic approaches in malignant mesothelioma. Cancer Trat Rev 4: 13–23Google Scholar
  100. 100.
    Legrand M, Pariente R (1976) Electron microscopy in the cytological examination of metastatic pleural effusions. Thorax 31: 443–449PubMedGoogle Scholar
  101. 101.
    Lewinsohn HC (1974) Early malignant changes in pleural plaque due to asbestos exposure. Br J Dis Chest 68: 121–127PubMedGoogle Scholar
  102. 102.
    Libshitz H (1984) Malignant pleural mesothelioma: The role of computed tomography. CT 8: 15–20PubMedGoogle Scholar
  103. 103.
    Light RW (1983) Pleura disease. Lea & Febiger, Philadelphia, USAGoogle Scholar
  104. 104.
    Lipscomb DJ, Flower CDR (1980) Ultrasound in the diagnosis and management of pleural disease. Br J Dis Chest 74: 361–363Google Scholar
  105. 105.
    Lochner B, Loddenkemper R, Claussen C, Wegener OH (1983) Thorakoskopische und computertomographisehe Befunde beim Pleuramesotheliom. Fortschr Röntgenstr 138: 570–576Google Scholar
  106. 106.
    Loddenkemper R (1981) Thoracoscopy: results in non cancerous and idiopathic pleural effusions. Poumon-Coeur 37: 261–264PubMedGoogle Scholar
  107. 107.
    Loddenkemper R, Engel J, Fabel H, Konietzko N, Magmussen H (1982) Diagnostisches Vorgehen beim Pleuraerguß. Prax Pneumol 36: 447–448Google Scholar
  108. 108.
    Loddenkemper R, Grosser H, Gabler A et al (1983) Prospective evaluation of biopsy methods in the diagnosis of malignant pleural effusion. Intrapatient comparison between pleural fluid cytology, blind needle biopsy and thoracoscopy. Am Rev Respir Dis 127: 4–114Google Scholar
  109. 109.
    Loddenkemper R (1985) Neoplasmen der Pleura. In: Trendelenburg F (ed) Tumoren der Atmungsorgane und des Mediastinums. Handbuch Innere Medizin. Springer-Verlag, Berl in HeidelbergGoogle Scholar
  110. 110.
    Löhr J, Klippe HJ, Kroger C (1981) Chirurgische Behandlung des Pleuramesothelioms, gegenwärtige kurative und palliative Möglichkeiten. Prax Pneumol 35: 394–399Google Scholar
  111. 111.
    Maassen W (1972) Direkte Thorakoskopie ohne vorherige oder mögliche Pneumothoraxanlage. Endoskopie 4: 95–98Google Scholar
  112. 112.
    Maassen W (1981) Thoracoscopy et biopsy pulmonaire sans pneumothorax initial. Poumon 37: 317–320Google Scholar
  113. 113.
    Magner D, McDonald AD (1972) Malignant mesothelioma tumors - histological types and asbestos exposure. N Engl J Med 287: 570–571PubMedGoogle Scholar
  114. 114.
    Martensson G (1981) Thoracoscopy in the diagnosis of malignant mesothelioma. Poumon Coeur 37: 249–251PubMedGoogle Scholar
  115. 115.
    Martensson G, Hagmar B, Zettergren L (1984) Diagnosis and prognosis in malignant pleural mesothelioma: A prospective study. Eur J Respir Dis 65: 168–178Google Scholar
  116. 116.
    Matzel W (1985) Biochemical and cytological features of diffuse mesotheliomas of the pleura. Arch Geschwulstforsch 55: 259–264PubMedGoogle Scholar
  117. 117.
    Matzel W, Schubert G (1979) Bestimmung des Hyaluronsäure-Gehaltes von Pleuraergüssen als Parameter klinischer Diagnostik diffuser Mesotheliome. Arch Geschwulstforsch 49: 146–154PubMedGoogle Scholar
  118. 118.
    McCormick PM, Nagasaki F, Hilamis BS, Martini N (1982) Surgical treatment of pleural mesothelioma. J Thorac Cardiovasc Surg 84: 834–842Google Scholar
  119. 119.
    McDonald AD, McDonald JC (1970) Epidemiology of primary malignant mesothelial tumors in Canada. Cancer 26: 914–919PubMedGoogle Scholar
  120. 120.
    McDonald AD, Magner D, Eyssen G (1973) Primary malignant mesothelioma tumors in Canada, 1960–1968. Cancer (Philad) 31: 869Google Scholar
  121. 121.
    McDonald JC, McDonald AD (1977) Epidemiology of mesothelioma from estimated incidence. Prev Med 6: 426–446PubMedGoogle Scholar
  122. 122.
    McDonald AD, McDonald JC (1978) Mesothelioma after crocidoliteexposure during gas mask manufacture. Environ Res 17: 340–346PubMedGoogle Scholar
  123. 123.
    McDonald AD, McDonald JC (1980) Malignant mesothelioma in North America. Cancer 46: 1650–1656PubMedGoogle Scholar
  124. 124.
    McDonald AD, McDonald JC, Pooley FD (1982) Mineral fibre content of lung in mesothelial tumors in North America. Ann Occup Hyg 26: 417–422PubMedGoogle Scholar
  125. 125.
    McDonald AD, McDonald JC (1987) Epidemiology of malignant mesothelioma. Grune & Stratton Inc., London, p 31Google Scholar
  126. 126.
    McKenna JM, Chandraschar A J, Henkin RE (1980) Diagnostic value of carcinoembryonic antigen in exudative pleural effusions. Chest 78: 587–590PubMedGoogle Scholar
  127. 127.
    Mehnert WH, Bender E, Graffi A et al (1974) Mesotheliome beim Goldhamster. Vi. Weitere Untersuchungen zur Makroskopie und Histologie mit Literaturübersicht. Arch Geschwulstforsch 43: 22PubMedGoogle Scholar
  128. 128.
    Milne JEH (1976) Thirty-two cases of mesothelioma in Victoria, Australia: A retrospective survey related to occupational asbestos exposure. Br J Ind Med 33: 115–122PubMedGoogle Scholar
  129. 129.
    Mintzer RA, Dugell DW (1982) The association of asbestos-induced pleural disease and rounded etelectasis. Chest 81: 457–460PubMedGoogle Scholar
  130. 130.
    Mirvis S, Dutcher JP, Haney PJ, Whitley NO, Aismer J (1983) CT of malignant pleural mesothelioma. AJR 140: 665–670PubMedGoogle Scholar
  131. 131.
    Moertel CG (1972) Peritoneal mesothelioma. Gastroenterology 63: 346–350PubMedGoogle Scholar
  132. 132.
    Müller KM (1983) Pleura. In: Doerr W, Scifert G (Hrsg) Pathologie der Lunge. Spezielle pathologische Anatomie, Bd. 16/11. Springer, Berlin Heidelberg New York Tokyo, p 1295–1398Google Scholar
  133. 133.
    Newhouse ML (1965) Epidemiology of mesothelial tumors in the London area. Ann NY Acad Sci 132: 579PubMedGoogle Scholar
  134. 134.
    Newhouse ML (1973) Cancer among workers in asbestos textile industry. In: Bogovski P, Gilson JD, Timbrell V et al (eds) Biological effects of asbestos. IARC, Scientific Publications (Lyon), p 203–208Google Scholar
  135. 135.
    Newhouse ML, Thompson H (1965) Mesothelioma of pleura and peritoneum following exposure to asbestos in the London area. Br J Ind Med 22: 261–269PubMedGoogle Scholar
  136. 136.
    Newhouse ML, Berry G, Wagner JC et al (1972) A study of the mortality of the female asbestos worker. Br J Ind Med 29: 134–141PubMedGoogle Scholar
  137. 137.
    Newhouse ML, Berry G (1976) Predictions of mortality from mesothelial tumors in asbestos factory workers. Br J Ind Med 33: 147–151PubMedGoogle Scholar
  138. 138.
    Norpoth K, Woitowitz HJ (1984) Krebsgefährdung am Arbeitsplatz: Das asbestverursachte Mesotheliom, eine neue Berufskrankheit. Dt Ärzteblatt 81: 2889Google Scholar
  139. 139.
    Nowinski DM, Muhm JR (1985) Malignant pleural mesothelioma: Chest radiograph and CT findings. Presented at Roentgen Ray, Boston, MA. p 21–26Google Scholar
  140. 140.
    Oels HC, Harrison EG, Carr D et al (1971) Diffuse malignant mesothelioma of the pleura: A review of 37 cases. Chest 60: 564PubMedGoogle Scholar
  141. 141.
    Okike N, Bernatz PE, Woolner LB (1978) Localized mesothelioma of the pleura. Benign and malignant variants. J Thorac Cardiovasc Surg 75: 363–372Google Scholar
  142. 142.
    Osteen RT (1987) Peritoneal mesothelioma. Grune & Stratton Inc, London, p 339Google Scholar
  143. 143.
    Otto H (1979) Versicherungsrechtliche Probleme bei der Beurteilung berufsbedingter Krebskrankheiten am Beispiel des Mesothelioms. Verh dtsch Ges Arbeitsmed eV, 19 Jahrestagung, Münster, Mai 1979, A.W. Genter, Stuttgart, p 283–295Google Scholar
  144. 144.
    Otto H (1980) Das berufsbedingte Mesotheliom in der BRD. Pathologe 2: 8–18PubMedGoogle Scholar
  145. 145.
    Otto H (1982) Das Mesotheliomregister der Bundesrepublik. Symposium des Bundesgesundheitsamtes Zur Beurteilung der Krebsgefahren durch Asbest. Kongreßband, BerlinGoogle Scholar
  146. 146.
    Palojoki A (1981) Thoracoscopy in the diagnosis of pleural diseases. Poumon Coeur 37: 63–65PubMedGoogle Scholar
  147. 147.
    Pelnar PU (1984) Non-asbestos related malignant mesothelioma - a review of the scientific and medical literature. Monography of the Canadian asbestos information centre, Montreal, p 1–12Google Scholar
  148. 148.
    Peterson JT jr, Greenberg SD, Buffier PA (1984) Non-asbestos-related malignant mesothelioma. Cancer 54: 951–960PubMedGoogle Scholar
  149. 149.
    Poole FD (1972) Electron microscopic characteristics of inhaled chrysotile asbestos fibers. Br J Ind Med 29: 146–153Google Scholar
  150. 150.
    Poole FD (1973) Mesothelioma in relation to exposure. In: Bogovski P, Gilson JD, Timbrell V et al (eds) Biological effects of asbestos. IARC Scientific Publications (Lyon), p 222–225Google Scholar
  151. 151.
    Pooley FD (1972) Asbestos bodies, their information, composition and character. Environ Res 5: 363–379PubMedGoogle Scholar
  152. 152.
    Porter JM, Cheek JM (1968) Pleural mesothelioma. J Thorac Cardiovasc Surg 55: 882PubMedGoogle Scholar
  153. 153.
    Pott F, Huth F, Friedrichs KH (1974) Tumorgenic effect of fibrous dusts in experiments animals. Environm Hlth Persp 9: 313–315Google Scholar
  154. 154.
    Pott F (1978) Some aspects on the dosimetry of the carcinogenic potency of asbestos and other fibrous dust. Staub-Reinhalt Luft 38: 486–490Google Scholar
  155. 155.
    Preger L (1978) Asbestos-related disease. Grune & Stratton, New York San Francisco LondonGoogle Scholar
  156. 156.
    Pugatch RD, Failing L, Robbins AH et al (1978) Differentiation of pleural and pulmonary lesions using computed tomography. J Comput Assist Tomogr 2: 601–606PubMedGoogle Scholar
  157. 157.
    Rabinowitz JG, Efremidis SC, Cohen B, Dan S, efremides A, Chahimian AP (1982) A comparative study of mesothelioma and asbestosis using tomography and conventional chest radiography. Radiology 144: 453–460PubMedGoogle Scholar
  158. 158.
    Ratzer ER, Pool JL, Melmamed MR (1967) Pleural mesothelioma. Clinical experience with 37 patients. Am J Roentgenol 99: 863–880Google Scholar
  159. 159.
    Reisner K, Huzly A (1967) Pleurogene Tumoren and Pseudotumoren der Pleura. I. u. II. Fortschr Röntgenstr 106: 775; 107: 68Google Scholar
  160. 160.
    Reshad K, Inui K, Taekuchi Y, Takahashi Y, Hitomi S (1985) Treatment of malignant pleural effusion. Chest 88: 393–397PubMedGoogle Scholar
  161. 161.
    Reuter K, Raptopoulos V, Reale F, Krolikowshi FJ, D’Orsi CJ, Graham S, Smith EH (1983) Diagnosis of peritoneal mesothelioma: Computed tomography, sonography and fine necale aspiration biopsy. AJR 140: 1189–1194Google Scholar
  162. 162.
    Risberg B, Nickels J, Wagermark J (1980) Familial clustering of malignant mesothelioma. Cancer 45: 2422–2427PubMedGoogle Scholar
  163. 163.
    Roberts GH (1970) Diffuse pleural mesothelioma. Brit J Dis Chest 64: 201PubMedGoogle Scholar
  164. 164.
    Roberts GH, Irvine RW (1970) Peritoneal mesothelioma. A Report of 4 cases. Brit J Surg 57: 645PubMedGoogle Scholar
  165. 165.
    Roberts GH (1976) Distant visceral metastases in pleural mesothelioma. Br J Dis Chest 70: 246–250PubMedGoogle Scholar
  166. 166.
    Rom WN, Travis WD, Brody AR (1991) Cellular and molcular basis of the asbestos-releated diseases. Am Rev Respir Dis 143: 408–422PubMedGoogle Scholar
  167. 167.
    Rtittner JR, Eidenbenz H, Wüst W (1974) Pleuramesotheliome in Zürich. Schweiz med Wschr 104: 340Google Scholar
  168. 168.
    Ryan CJ, Rodgens RF, Unmik K, Hepper NG (1981) The outcome of patients with pleural effusion of indeterminate cause at thoracotomy. Mayo Clin Pre 56: 145–149Google Scholar
  169. 169.
    Saracci R, Simomato L, Baris Y, Artrimli M, Skidmore J (1982) The age-mortality curve of endemic pleural mesothelioma in Karain Central Turkey. Brit J Cancer 45: 147–149PubMedGoogle Scholar
  170. 170.
    Scharkoff T (1965) Das solitäre Pleuramesotheliom. Zbl Chir 90: 2289PubMedGoogle Scholar
  171. 171.
    Schuster G, Huzly A (1974) Operative Behandlung von primären und sekundären diffusen Pleuratumoren. Thoraxchirurgie 22: 394–397Google Scholar
  172. 172.
    Selikoff IJ, Hammond EC, Scidman H (1973) Cancer risk of installation workers in the United States. In: Bogovski P, Gilson JD, Timbrell V et al (eds) Biological effects of asbestos. IARC Scientific Publications (Lyon), p 209–216Google Scholar
  173. 173.
    Selikoff IJ, Lee DGH (1978) Asbestos and disease. Acad Press, New York, p 244–245Google Scholar
  174. 174.
    Selikoff IJ, Hammond EC (ed) (1979) Health hazards of asbestos exposure. Ann NY Acad Sci 330, New YorkGoogle Scholar
  175. 175.
    Selikoff I J, Hammond EC, Scidman H (1980) Latency of asbestos disease among insulation workers in the United States and Canada. Cancer 46: 2730–2736Google Scholar
  176. 176.
    Seydel HG (1987) Radiation therapy for pleural mesothelioma. Grune & Stratton Inc., London, p 339Google Scholar
  177. 177.
    Shemin RJ (1987) Peritoneal mesothelioma. Grune & Stratton Inc., London, p 357Google Scholar
  178. 178.
    Shin MS, Bailey WC (1983) Computed tomography of invasive pleural mesothelioma. CT 7: 389–394PubMedGoogle Scholar
  179. 179.
    Shuman LS, Libshitz HI (1984) Solid pleural manifestations of lymphoma. AJR 142: 269–273PubMedGoogle Scholar
  180. 180.
    Singh G, Whiteside TL, Dekker A (1979) Immundiagnosis of mesothelioma. Use for antimesothelial cell serum in an indirect immunfluorescence assay. Cancer 43: 2288–2296Google Scholar
  181. 181.
    Solomon A (1987) The radiology of asbestosis and related neoplasms. Grune & Stratton Inc., London, p 239Google Scholar
  182. 182.
    Solomons K (1984) Malignant mesothelioma - clinical and epidemiological features. A report of 80 cases. SA Med 66: 407–412Google Scholar
  183. 183.
    Stanton MF, Wrench C (1972) Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst 48: 797–821PubMedGoogle Scholar
  184. 184.
    Stanton MF, Layard M, Tegeris A et al (1977) Carcinogenicity of fibrous glass: pleural response in the rats in relation to fiber dimension. J Natl Cancer Inst 58: 587–603PubMedGoogle Scholar
  185. 185.
    Stanton MF, Layard M, Tegris A, Miller E, May M, Morgan E, Smith A (1981) Relation of particle dimensions to carcinogenicity in amphibole asbestos and other fibrous minerals. J Natl Cancer Inst 67: 965–975PubMedGoogle Scholar
  186. 186.
    Stark P (1981) Das fibröse Pleuramesotheliom (Pleurafibrom). Ein Beitrag zur Differentialdiagnose von Pleuratumoren. Fortschr Röntgenstr 134: 614–619Google Scholar
  187. 187.
    Steiner RM, Cooper MW, Brodovsky H (1982) Rib-destruction: A neglected finding in malignant mesothelioma. Clin Radiol 33: 61–65Google Scholar
  188. 188.
    Stössel HG, Dalquen P, Carstens U (1972) Zur Frage des Pleuramesothelioms bei Werftarbeitern. Fortschr Röntgenstr 116: 41Google Scholar
  189. 189.
    Sytman AL, MacAlpin RN (1971) Primary pericardial mesothelioma: report of two cases and review of the literature. Am Heart J 81: 760–769PubMedGoogle Scholar
  190. 190.
    Taryle DA, Lakshminarayan S, Sahn SA (1976) Pleural mesothelioma - An analysis of 18 cases and review of the literature. Medicine 55: 153–162PubMedGoogle Scholar
  191. 191.
    Triol JH, Conston AS, Candler SV (1984) Malignant mesothelioma-cytopathology of 75 cases seen in a New Jersey community hospital. Acta Cytologica 28: 37–45PubMedGoogle Scholar
  192. 192.
    Valentin H, Lehner G, Petry H et al (1979) Arbeitsmedizin, Bd. 2: Berufskrankheiten. Thieme, Stuttgart, p 187–214Google Scholar
  193. 193.
    Voss A-C, Wöllgens P, Untucht HJ (1974) Das Pleuramesotheliom aus strahlentherapeutischer Sicht. Strahlentherapie 148: 329–332Google Scholar
  194. 194.
    Vogt-Moykopf I, Krumhaar D, Lüllig H et al (1974) Zur Diagnostik und prognostischen Bedeutung des Pleuraergusses bei Malignitätsverdacht. Thoraxchirurgie 22: 398–401Google Scholar
  195. 195.
    Vogt-Moykopf I, Etspüler W, Bülzebrode H (1987) Das diffuse Pleuramesotheliom-Diagnostik, Therapie und Prognose. Z Herz- Thorax- und Gefäßchirurgie 1: 67–78Google Scholar
  196. 196.
    Wallach HW (1975) Intrapleural tetracycline for malignant pleural effusion. Chest 68: 510–512PubMedGoogle Scholar
  197. 197.
    Wang NS, Huang SN, Gold P (1979) Absence of carcinoembryonie antigen-like material in mesothelioma. An immunohistological differentiation from other lung cancers. Cancer 44: 937–943Google Scholar
  198. 198.
    Wagner DC, Sleggs CA, Marchaud P (1960) Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 17: 260–271PubMedGoogle Scholar
  199. 199.
    Warhol MJ (1987) Electron microscopy in the diagnosis of mesothelioma with routine biopsy, needle biopsy and fluid cytology. Grune & Stratton Inc., London, p 201Google Scholar
  200. 200.
    Waxier B, Eisenstein R, Battifora H (1979) Electrophoreses of tissue glycosaminoglycans as an aid in the diagnosis of mesothelioma. Cancer 44: 221–227Google Scholar
  201. 201.
    Wedermann K, Greschuchna D, Maassen W (1974) Ergebnisse chirurgischer Lungen- und Pleura-biopsien. Thoraxchirurgie 22: 453–456Google Scholar
  202. 202.
    Weill H, Ziskind MM, Wagenspack C et al (1975) Lung function consequences of dust exposure in asbestos cement manufacturing plants. Arch Environ Health 30: 88–97PubMedGoogle Scholar
  203. 203.
    Weill H, Rossiter CE, Waggenspack C et al (1977) Differences in lung effects resulting from chrysotile and crocidolite exposure. In: Walton WH (ed) Inhaled particles IV. Pergamon Press, Oxford New York, p 789–798Google Scholar
  204. 204.
    Whitaker D, Shilkin KB (1984) Diagnosis of pleural malignant mesothelioma in life - A practical approach. J of Pathol 143: 147–175Google Scholar
  205. 205.
    Whitley NO (1987) Computed tomography and malignant mesothelioma. Grune & Stratton Inc, London, p 265Google Scholar
  206. 206.
    Whitley NO, Brenner DE, Antman KH, Grant D, Ailsmer J (1982) CT of peritoneal mesothelioma: Analysis of eight cases. AJR 138: 531–535Google Scholar
  207. 207.
    Whitwell F, Rawcliffe RM (1971) Diffuse malignant pleural mesothelioma and asbestos exposure. Thorax 26: 6PubMedGoogle Scholar
  208. 208.
    Whitwell F, Scott J, Grimshaw M (1977) Relationship between occupations and asbestos-fibre content of the lungs in patients with pleural mesothelioma, lung cancer, and other diseases. Thorax 32: 377–386PubMedGoogle Scholar
  209. 209.
    Wimmer B (1980) Sonographische Diagnostik von Tumoren der Thoraxwand. Fortschr Röntgenstr 132: 633–638Google Scholar
  210. 210.
    Wörn H (1974) Möglichkeiten und Ergebnisse der chirurgischen Behandlung des malignen Pleura-mesothelioms. Thoraxchirurgie 22: 391–393Google Scholar
  211. 211.
    Woitowitz HJ (1972) Arbeitsmedizinisch-epidemiologische Untersuchung zu den unmittelbaren Gesundheitsgefahren durch Asbest. Schriftenreihe Arbeit und Gesundheit, Neue Folge H 86. Thieme, StuttgartGoogle Scholar
  212. 212.
    Woitowitz HJ (1980) Tumorepidemiologie. In: Luftqualitätskriterien. Umweltbelastung durch Asbest und andere faserige Feinstäube. Berichte 7/80. Umweltbundesamt. E. Schmidt, Berlin, p 203–266Google Scholar
  213. 213.
    Woitowitz HJ, Paur R, Breuer G, Rodelsperger K (1984) Das Mesotheliom, ein Signaltumor der beruflichen Asbeststaubgefährdung. Dtsch Med Wschr 10: 363–368Google Scholar
  214. 214.
    Yap BS, Benjamin RS, Burgess A et al (1978) The value of adriamycin in the treatment of diffuse malignant pleural mesothelioma. Cancer 42: 1692–1696PubMedGoogle Scholar
  215. 215.
    Yazicioglu S (1976) Pleural calcification associated with exposure to chrysotile asbestos in southeast Turkey. Chest 70: 43–47PubMedGoogle Scholar
  216. 216.
    Yeh HC, Chahinian AP (1980) Ultrasonography and computed tomography of peritoneal mesothelioma. Radiology 135: 705–712PubMedGoogle Scholar
  217. 217.
    Young JR, Reddy ER (1980) Peritoneal mesothelioma. Clin Radiol 31: 243–247PubMedGoogle Scholar
  218. 218.
    Zielhuis RL, Versteeg JPG, Planteudt HT (1975) Pleural mesothelioma and exposure to asbestos. Int Arch Occup Environ Health 36: 1–18PubMedGoogle Scholar
  219. 219.
    Zielhuis RL (1977) Public health risks of exposure to asbestos. Pergamon Press for the commission of the european communities, LuxemburgGoogle Scholar
  220. 220.
    Zober MA (1987) Pleuramesotheliome im Betrieb - Eine empirisch-kasuistische Untersuchung. Arbeitsmedizin-Sozialmedizin-PräventivmedizinGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1992

Authors and Affiliations

  • N. Konietzko
    • 1
  • H. Teschler
    • 1
  1. 1.Ruhrlandklinik Zentrum für Pneumologie und Thoraxchirurgie Abteilung für PneumologieUniversitätsklinikEssen 16Deutschland

Personalised recommendations